Advances and Updates in Lung Cancer Webcourse

This course is meant to be an adjunct to the ONS Site-Specific Cancer Series: Lung Cancer course. The textbook of the same name is not utilized for this adjunct course but continues to be a beneficial resource for nurses caring for patients with lung cancers. Although not required as a prerequisite, the ONS Site-Specific Cancer Series: Lung Cancer course is recommended to be taken prior to this course. This course will discuss some of the more advanced concepts related to diagnostic, treatment and supportive care issues for lung cancer including the newest staging guidelines for NSCLC. The inclusion of learning activities, journal articles, website links and video prestations provide a variety of formats for learning opportunities within the course.

Categories: Type of Cancer/Lung Cancer

FormatWebcourse
Contact Hours4.6
Member Price$49
Non-Member Price$69
Contacteducationcourses@ons.org
Technical RequirementsTechnical Requirements

Upcoming Dates

No upcoming programs scheduled

Date Location Instructor Registration Deadline
07/09/2013 - 08/06/2013 ONS Online Courses 07/01/2013 11:59 PM
11/19/2013 - 12/17/2013 ONS Online Courses 11/11/2013 11:59 PM

Participate

ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

Certification Blueprint Topic for ILNA
OCN Blueprint Topic: Screening, early detection and diagnosis; Scientific basis for practice including research; Symptom Management; Survivorship
AOCNP Blueprint Topic: Screening, Prevention, Early Detection, Genetic Risk; Side Effect & Symptom Management; Survivorship
AOCNS Blueprint Topic: Screening, Prevention, Early Detection, Genetic Risk; Side Effect & Symptom Management; Survivorship

Learn more about the ILNA Renewal Method.

Course Objectives

 
Discuss screening and the emerging role of pharmacogenetic testing in lung cancer.
Describe the standard treatments for lung cancer types based on the revised staging criteria.
Discuss at least two (2) supportive care and/or survivorship issues that lung cancer patients face.